AQUILON PHARMACEUTICALS
The computed 12-month bankruptcy probability of AQUILON PHARMACEUTICALS is 0.7% (low). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 12 yrs |
| Locations | 4 |
| Publications | 13 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 29-07-2025 | 2025-00322216 |
| 31-12-2023 | volledig | 25-07-2024 | 2024-00281308 |
| 31-12-2022 | volledig | 10-07-2023 | 2023-00217875 |
| 31-12-2021 | volledig | 02-08-2022 | 2022-20260740 |
| 31-12-2020 | volledig | 26-08-2021 | 2021-54800537 |
| 31-12-2019 | volledig | 16-07-2020 | 2020-30700174 |
| 31-12-2018 | volledig | 24-06-2019 | 2019-22500580 |
| 31-12-2017 | volledig | 16-07-2018 | 2018-33200354 |
| 31-12-2016 | volledig | 12-07-2017 | 2017-30200388 |
| 31-12-2015 | volledig | 18-07-2016 | 2016-32800107 |
| NACE primary | 72101 |
| Legal form | Public limited company(014) |
| Incorporation | 16-10-2013 |
| Status | Active |
| Postal code | 4102 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0323/00M003 | Wallonia | 8,679 m² | 1 · 791 m² | 18.8 m · 5 fl. |
| 62108C0666/00X000 | Wallonia | 1,360 m² | 1 · 191 m² | 8.6 m · 2 fl. |
| 62817C0199/00G002 | Wallonia | 918 m² | 1 · 541 m² | — |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
16-09-2025 1 director appointed, 1 resigning
- Charles Nelles — Bestuurder
- Michael Mellink — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael Mellink",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-08-01",
"evidence_quote": "la pr\u00E9sente assembl\u00E9e a \u00E9t\u00E9 convoqu\u00E9e avec l\u0027ordre du jour suivant : - D\u00E9mission de Monsieur Michael Mellink en tant qu\u0027administrateur avec effet imm\u00E9diat;",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Charles Nelles",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2025-08-01",
"evidence_quote": "Nomination de Monsieur Charles Nelles en tant qu\u0027administrateur avec effet imm\u00E9diat et pour une dur\u00E9e de 6 ans:",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 6
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Michael Mellink",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "La d\u00E9mission avec effet imm\u00E9diat de Monsieur Michael Mellink a \u00E9t\u00E9 accept\u00E9e;",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Charles Nelles",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "La nomination, avec effet imm\u00E9diat, de Monsieur Charles Nelles pour une dur\u00E9e de 6 ans a \u00E9t\u00E9 accept\u00E9e.",
"decharge_status": "granted",
"mandate_duration": {
"kind": "n_years",
"value": 6
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Liege",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-09-16",
"filing_date": "2025-08-01",
"act_kind_objet": "Objet de l\u0027acte"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-07-02",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "SA",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0473.951.403",
"org_name": "JACQUES \u0026 ASSOCIES SRL",
"person_name": null,
"org_rep_person_name": "Julien JACQUES",
"person_role_at_subject": null
},
"co_filed_documents": [
"Proc\u00E8s-verbal de l\u0027AGO du 02/07/2025"
],
"corrected_publication_numac": null
}04-07-2025 Capital increase of €1,823,821.43 to €5,936,277.23
- €4.112.455,80 → €5.936.277,23
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 5936277.23,
"delta_eur": 1823821.43,
"before_eur": 4112455.8,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 39516,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 46.154
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 1823821.43,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 5486277.23,
"delta_eur": -450000.0,
"before_eur": 5936277.23,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-07-04",
"filing_date": "2025-07-02",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-07-02",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "David DEMONCEAU"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 43420,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 70616,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 42414,
"class_name": "C",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 97211,
"class_name": "D",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 9013,
"class_name": "E",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}04-07-2025 Articles of association amended — translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-07-04",
"filing_date": "2025-07-02",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-07-02",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "capital_change_consequence",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"individual_name": "David DEMONCEAU"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full_after": "AQUILON PHARMACEUTICALS",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"name_full_before": "AQUILON PHARMACEUTICALS",
"current_zetel_raw": "Rue du Bois St-Jean 15/1, 4102 Seraing",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "Le capital est fix\u00E9 \u00E0 5.486.277,23 \u20AC et repr\u00E9sent\u00E9 par 262.674 actions sans d\u00E9signation de valeur nominale, dont 43.420 de classe A, 70.616 de classe B, 42.414 de classe C, 97.211 de classe D, et 9.013 de classe E.",
"new_text": "Le capital est fix\u00E9 \u00E0 cinq millions quatre cent quatre-vingt-six mille deux cent septante-sept euros vingt-trois cents (5.486.277,23 \u20AC). Il est repr\u00E9sent\u00E9 par 262.674 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/262.674e de l\u2019avoir social, dont 43.420 actions de classe A, 70.616 actions de classe B, 42.414 actions de classe C, 97.211 actions de classe D, ",
"change_kind": "amended",
"article_title": null,
"article_number": "5 \u00A71er"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Geoffrey GAUTHY",
"org_rep_person_name": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_kind",
"share_class_creation"
],
"split_ratio": null,
"shares_after": 262674,
"shares_before": 262674,
"capital_after_eur": 5486277.23,
"capital_before_eur": 4112455.8,
"share_classes_after": [
{
"count": 7521,
"label": "A",
"rights_summary": "Droit de vote",
"voting_per_share": 1.0
},
{
"count": 7796,
"label": "C",
"rights_summary": "Droit de vote",
"voting_per_share": 1.0
},
{
"count": 24199,
"label": "D",
"rights_summary": "Droit de vote",
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}22-05-2025 Capital increase of €466,056.96 to €4,112,455.80
- €3.646.398,84 → €4.112.455,80
- Inbreng in natura · Apport en nature
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 3646398.84,
"delta_eur": 430304.0,
"before_eur": 3216094.84,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 15368,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 28.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 430304.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 4112455.8,
"delta_eur": 466056.96,
"before_eur": 3646398.84,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 16658,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": 466056.96,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-05-22",
"filing_date": "2025-05-20",
"act_kind_objet": "Objet de l\u0027acte : STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-05-20",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "David DEMONCEAU"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 35899,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 70616,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 34618,
"class_name": "C",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 73012,
"class_name": "D",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 9013,
"class_name": "E",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}22-05-2025 Articles of association amended — translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-05-22",
"filing_date": "2025-05-20",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-05-20",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "capital_change_consequence",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"individual_name": "David DEMONCEAU"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full_after": "AQUILON PHARMACEUTICALS",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"name_full_before": "AQUILON PHARMACEUTICALS",
"current_zetel_raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "The article defining the capital and share structure was replaced with new text reflecting the post-increase capital of \u20AC4,112,455.80 and the new share class distribution.",
"new_text": "Le capital est fix\u00E9 \u00E0 quatre millions cent douze mille quatre cent cinquante-cinq euros quatre-vingt cents (4.112.455,80 \u20AC). Il est repr\u00E9sent\u00E9 par 223.158 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/222.593e de l\u2019avoir social, dont 35.899 actions de classe A, 70.616 actions de classe B, 34.618 actions de classe C, 73.012 actions de classe D, et 9.013 act",
"change_kind": "amended",
"article_title": null,
"article_number": "5 \u00A7 1er"
},
{
"summary": "The article defining the annual general meeting date was replaced with new text.",
"new_text": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire se r\u00E9unit annuellement le dernier jeudi de juin \u00E0 seize heures.",
"change_kind": "amended",
"article_title": null,
"article_number": "24 alin\u00E9a 1er"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Geoffrey GAUTHY",
"org_rep_person_name": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": "*25333276*",
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": false
},
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_cash",
"capital_increase_kind",
"share_class_creation"
],
"split_ratio": null,
"shares_after": 223158,
"shares_before": 206500,
"capital_after_eur": 4112455.8,
"capital_before_eur": 3646398.84,
"share_classes_after": [
{
"count": 35899,
"label": "A",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 70616,
"label": "B",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 34618,
"label": "C",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 73012,
"label": "D",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 9013,
"label": "E",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}22-05-2025 Registered office moved from Visé to Seraing
- Rue Porte de Lorette(VIS) 76 : 4600 Visé → 4102 Seraing, rue du Bois Saint-Jean, 15/1
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_administratif",
"new_address": {
"raw": "4102 Seraing, rue du Bois Saint-Jean, 15/1",
"city": "Seraing",
"region": "waals_gewest",
"street": "du Bois Saint-Jean",
"country": "BE",
"postcode": "4102",
"box_number": null,
"street_number": "15/1",
"locality_suffix": null
},
"old_address": {
"raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
"city": "Vis\u00E9",
"region": "waals_gewest",
"street": "Porte de Lorette",
"country": "BE",
"postcode": "4600",
"box_number": null,
"street_number": "76",
"locality_suffix": "(VIS)"
},
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "not_specified",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-05-22",
"filing_date": "2025-05-20",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2025-05-20",
"unanimous": null
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
]
}16-04-2025 2 reappointed
- Paul Maes — Commissaris
- Gauthier Van Der Elst — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Paul Maes",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Maes PharmConsult Srl",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-06-04",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gauthier Van Der Elst",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Scale I",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": "2024-06-04",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Vis\u00E9",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-04-16",
"filing_date": "2024-06-04",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-07-16",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "SRL Jacques \u0026 Associ\u00E9s",
"person_name": "Julien JACQUES",
"org_rep_person_name": "Julien JACQUES",
"person_role_at_subject": "mandataire"
},
"co_filed_documents": [
"copie du Proc\u00E8s-verbal de I\u0027AGO du 16/07/2024",
"procuration"
],
"corrected_publication_numac": null
}20-03-2025 Capital increase of €449,990.19 to €3,465,910.84
- €3.015.920,65 → €3.465.910,84
- Inbreng in natura · Apport en nature
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 2766104.65,
"delta_eur": 249816.0,
"before_eur": 2516288.65,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 8922,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 28.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 249816.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 3015920.65,
"delta_eur": 249816.0,
"before_eur": 2766104.65,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 8922,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 28.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 249816.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 3465910.84,
"delta_eur": 449990.19,
"before_eur": 3015920.65,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 16251,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 27.69
},
"decrease_purpose": null,
"contribution_type": "natura",
"paid_up_delta_eur": 449990.19,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": null,
"office_city": "Herstal",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-03-20",
"filing_date": "2025-03-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-03-14",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "David DEMONCEAU"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 31446,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 59716,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 30149,
"class_name": "C",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 61166,
"class_name": "D",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 8655,
"class_name": "E",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}23-12-2024 Articles of association amended — translation of the articles, coordination of the articles and amendment of specific articles
Technical details
{
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-12-23",
"filing_date": "2024-12-19",
"act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-19",
"unanimous": null
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"targeted_amendment"
],
"scope": "full_restatement",
"trigger": "other",
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"individual_name": "DEMONCEAU David"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full_after": "AQUILON PHARMACEUTICALS",
"legal_form_after": "Soci\u00E9t\u00E9 anonyme",
"name_full_before": "AQUILON PHARMACEUTICALS",
"current_zetel_raw": "Rue Porte de Lorette(VIS) 76 : 4600 Vis\u00E9",
"legal_form_before": "Soci\u00E9t\u00E9 anonyme"
},
"special_mandates": [],
"articles_modified": [
{
"summary": "Le capital est fix\u00E9 \u00E0 2.516.288,65 \u20AC et repr\u00E9sent\u00E9 par 165.959 actions sans d\u00E9signation de valeur nominale, dont 5 classes (A \u00E0 E) jouissant des m\u00EAmes droits.",
"new_text": "Le capital est fix\u00E9 \u00E0 deux millions cinq cent seize mille deux cent quatre-vingt-huit euros soixante-cinq cents (2.516.288,65 \u20AC). Il est repr\u00E9sent\u00E9 par 165.959 actions avec droit de vote, sans d\u00E9signation de valeur nominale, repr\u00E9sentant chacune 1/165.959e) de l\u2019avoir social, dont 27.876 actions de classe A, 43.465 actions de classe B, 29.792 actions de classe C, 56.171 actions de classe D, et 8.6",
"change_kind": "amended",
"article_title": null,
"article_number": "5 \u00A71er"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Geoffrey GAUTHY",
"org_rep_person_name": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_kind",
"share_class_creation"
],
"split_ratio": null,
"shares_after": 165959,
"shares_before": 165959,
"capital_after_eur": 2516288.65,
"capital_before_eur": 2619395.19,
"share_classes_after": [
{
"count": 27876,
"label": "A",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 43465,
"label": "B",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 29792,
"label": "C",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 56171,
"label": "D",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
},
{
"count": 8655,
"label": "E",
"rights_summary": "droit de vote",
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}23-12-2024 Capital decrease of €450,000 to €2,516,288.65
- €2.966.288,65 → €2.516.288,65
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 2966288.65,
"delta_eur": 346893.46,
"before_eur": 2619395.19,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 7516,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 46.154
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 346893.46,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 2516288.65,
"delta_eur": -450000.0,
"before_eur": 2966288.65,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2024-12-23",
"filing_date": "2024-12-19",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-12-19",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "DEMONCEAU David"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 27876,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 43465,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 29792,
"class_name": "C",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 56171,
"class_name": "D",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 8655,
"class_name": "E",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}14-11-2023 Capital decrease of €762,000 to €2,619,395.19
- €3.381.395,19 → €2.619.395,19
- 2 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 3381395.19,
"delta_eur": 348278.08,
"before_eur": 3033117.11,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 7546,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 46.154
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": 348278.08,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 2619395.19,
"delta_eur": -762000.0,
"before_eur": 3381395.19,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Geoffrey GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-11-14",
"filing_date": "2023-11-10",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-11-09",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "AXYLIUM AUDIT \u2013 LIEGE",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "DEMONCEAU David"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations et les rapports",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 26924,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 43465,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 28335,
"class_name": "C",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 51064,
"class_name": "D",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 8655,
"class_name": "E",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}17-02-2023 5 directors appointed, 3 resigning
- BENAMEUR Hassan — Bestuurder
- MELLINK Michäel — Bestuurder
- MANOR Moshe — Bestuurder
- VAN DER ELST Gauthier — Bestuurder
- David DEMONCEAU — Bestuurder
- JEANMART Patrick — Bestuurder
- DE GHELDERE Joseph — Bestuurder
- STREEL Micheline — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "JEANMART Patrick",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 Monsieur JEANMART Patrick",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "DE GHELDERE Joseph",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 Monsieur DE GHELDERE Joseph",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "STREEL Micheline",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "end_of_term",
"subkind": null,
"via_org": {
"kbo": null,
"name": "SAMBRINVEST SPIN-OFF/SPIN-OUT",
"address": null,
"country": null,
"legal_form": null
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de mettre un terme aux fonctions d\u2019administrateur de : \u00B7 La soci\u00E9t\u00E9 \u00AB SAMBRINVEST SPIN-OFF/SPIN-OUT \u00BB dont le repr\u00E9sentant permanent est Madame STREEL Micheline",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "BENAMEUR Hassan",
"address": "69003 Lyon (France), rue Pierre Bonnaud, 61",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur BENAMEUR Hassan, domicili\u00E9 \u00E0 69003 Lyon (France), rue Pierre Bonnaud, 61, comme administrateur ind\u00E9pendant",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MELLINK Mich\u00E4el",
"address": "Hilversumseweg 14a 1251EX Laren (Pays-Bas)",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur MELLINK Mich\u00E4el, domicili\u00E9 \u00E0 Hilversumseweg 14a 1251EX Laren (Pays-Bas), comme administrateur de classe B",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "MANOR Moshe",
"address": "Hacarmek st, Ramat Hasharon, 4723007 Israel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e appelle aux fonctions d\u2019administrateurs : \u00B7 Monsieur MANOR Moshe, domicili\u00E9 \u00E0 Hacarmek st, Ramat Hasharon, 4723007 Israel, comme administrateur de classe D",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "VAN DER ELST Gauthier",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Suite \u00E0 la r\u00E9solution qui pr\u00E9c\u00E8de, l\u2019assembl\u00E9e g\u00E9n\u00E9rale constate que Monsieur VAN DER ELST Gauthier est un administrateur des classes C et E.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "David DEMONCEAU",
"address": null,
"birth_date": null,
"profession": "r\u00E9viseur d\u2019entreprises",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "SAINTENOY, COMHAIRE \u0026 CO",
"address": null,
"country": null,
"legal_form": null
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "du rapport \u00E9tabli par la soci\u00E9t\u00E9 \u00AB SAINTENOY, COMHAIRE \u0026 CO \u00BB, repr\u00E9sent\u00E9e par Monsieur David DEMONCEAU, r\u00E9viseur d\u2019entreprises, en date du 27 janvier 2023",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "correction",
"role": null,
"person": null,
"reason": null,
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Jean-Michel GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-02-17",
"filing_date": "2023-02-15",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2023-02-13",
"unanimous": null
},
{
"body": "algemene_vergadering",
"date": "2018-11-30",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jean-Michel GAUTHY",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du r\u00E9viseur",
"la coordination des statuts"
],
"corrected_publication_numac": null
}17-02-2023 Capital increase of €1,509,881.96 to €4,543,000.07
- €3.033.117,11 → €4.543.000,07
- 3 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "JEANMART Patrick",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "SAMBRINVEST SPIN-OFF/SPIN-OUT",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "DE GHELDERE Joseph",
"share_class": null,
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "BENAMEUR Hassan",
"share_class": "B",
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "MELLINK Mich\u00E4el",
"share_class": "B",
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "MANOR Moshe",
"share_class": "D",
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "VAN DER ELST Gauthier",
"share_class": "C",
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "VAN DER ELST Gauthier",
"share_class": "E",
"liberation_pct": null,
"contribution_kind": null,
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 1523235.16,
"delta_eur": -1201147.77,
"before_eur": 2724382.93,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 3033117.11,
"delta_eur": 1509881.95,
"before_eur": 1523235.16,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 32714,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 46.154
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 4543000.07,
"delta_eur": 1509881.96,
"before_eur": 3033117.11,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": null,
"n_new_shares": 32714,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 46.154
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Jean-Michel GAUTHY",
"firm_city": null,
"firm_name": "GAUTHY, JACQUES \u0026 ROLANS \u2013 Soci\u00E9t\u00E9 Notariale",
"office_city": "Herstal",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-02-17",
"filing_date": "2023-02-15",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-02-13",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "SAINTENOY, COMHAIRE \u0026 CO",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "David DEMONCEAU"
},
"subject_company": {
"kbo": "0540.870.218",
"name_full": "AQUILON PHARMACEUTICALS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019assembl\u00E9e comprenant les procurations, le rapport du CA et le rapport du r\u00E9viseur",
"la coordination des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 26924,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 43465,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 27130,
"class_name": "C",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 44723,
"class_name": "D",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 8655,
"class_name": "E",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | AQUILON PHARMACEUTICALS |